JACOB MANDEL to Survival Rate
This is a "connection" page, showing publications JACOB MANDEL has written about Survival Rate.
Connection Strength
0.119
-
Highlighting the need for reliable clinical trials in glioblastoma. Expert Rev Anticancer Ther. 2018 10; 18(10):1031-1040.
Score: 0.100
-
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
Score: 0.019